Skip to main content
. Author manuscript; available in PMC: 2021 Mar 9.
Published in final edited form as: Langmuir. 2020 Jun 5;36(23):6531–6539. doi: 10.1021/acs.langmuir.0c00947

Figure 6. In vivo pilot study for vaccinated mice inoculated with 4T1 tumor.

Figure 6.

(A) In vitro assay comparing T cell activation for PBS vs TNL-treated spleenocytes. (B) Timeline for in vivo study (C) IVIS imaging of mice using bioluminescent and Luc-expressing 4T1 cells (D) Tumor size over time for measurements taken via caliper (E) Days of metastasis observation post-tumor inoculation (F) Survival curve. Statistical significance determined by two-tailed ANOVA. *p<0.05, **p<0.01, ***p<0.005